Adult HIV treatment guidelines updated.
On April 8 the U.S. Food and Drug Administration (FDA) published the following description of the changes made in the current revision:
The Guidelines for the Use of Antiretroviral Agents in HIV-Y-Infected Adults and Adolescents has been revised to include up-to-date drug information, including updated information on nevirapine hepatotoxicity risks, the interaction between rifampin and ritonavirboosted saquinavir, new pregnancy data for efavirenz, and new contraindications and warnings for ritonavir and lopinavir/ritonavir use. Also included in the updated document is a new table, Table 30, providing information on the tipranavir expanded access program. All changes to the document are highlighted in yellow. The updated guidelines document is available at the AIDSinfo Web site at: http://www.aidsinfo.nih.gov/. You can view, order hard copies of the guidelines, or request them by email at the web site. The AIDSinfo website is also a useful source of other information related to HIV/AIDS, including other treatment and prevention guidelines, downloadable databases for PDAs (Personal Digital Assistants), and HIV/AIDS--related clinical trials information.
|Printer friendly Cite/link Email Feedback|
|Publication:||AIDS Treatment News|
|Date:||Mar 25, 2005|
|Previous Article:||Medicaid cuts alert.|
|Next Article:||In-Depth medical reports on the retroviruses conference.|